4th Quarter - Termination

PODESTA GROUP, INC. for BIOTECHNOLOGY INDUSTRY ORGANIZATION

Firm
Client
Income
$30,000
Expenses
—
Terminated
Dec 31, 2016

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 3056 - Creating and Restoring Equal Access to Equivalent Samples Act S. 1878 - Advancing Hope Act S. 2912 - Trickett Wender Right to Try Act H.R. 5122 CMMI Medicare Part B proposed demonstration Medicare Part D prescription drug program Medicare Part B payment and coding issues Senate HELP biomedical innovation/H.R. 6 - 21st Century Cures Act Value-based contracting and communications

LobbyistCovered position, as disclosed
ANNA KATHERINE WEINSTEIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2912 (114th), S. 3056 (114th), H.R. 5122 (114th), S. 1878 (114th), H.R. 6 (114th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.